JNK-IN-14 TFA
JNK-IN-14 TFA is a potent and selective JNK inhibitor with IC50 values of 1.81, 12.7 and 10.5 nM for JNK1, JNK2 and JNK3, respectively. JNK-IN-14 TFA induces early-stage apoptosis and G2/M cell cycle arrest. JNK-IN-14 TFA can be used for cancer research
For research use only. We do not sell to patients.
- Formula: C29H32F3N5O6S
- Molecular Weight:635.65
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
JNK-IN-14 (compound 11e) (2.5 μM-5 μM, 24 h) TFA leads to slight early-stage apoptosis in a concentration-dependent manner in K562 cells[1].
JNK-IN-14 (1.25-5 μM, 24 h) TFA induces G2/M cell cycle arrest in K562 cells[1].
JNK-IN-14 TFA exhibits a GI50 of 1.28 μM against NCI K562 cells[1].
JNK-IN-14 (2.5 μM-5 μM, 24 h) TFA inhibits beclin-1 production in K562 leukemia cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:K562 Human Leukemia Cell
-
Concentration:1.25 μM, 2.5 μM, 5 μM
-
Incubation Time:24 h
-
Result:Showed viable cells arrest at the G2/M phase with values of 45.33% at 1.25 μM, 2.5 μM at 62.99%, and 5 μM at 98.97%.
-
Cell Line:K562 Human Leukemia Cell
-
Concentration:2.5 μM, 5 μM
-
Incubation Time:24 h
-
Result:Resulted in early-stage apoptosis with 1.94%, and 2.14% for 2.5 and 5 μM, respectively.
-
Cell Line:K562 Human Leukemia Cell
-
Concentration:2.5 μM, 5 μM
-
Incubation Time:24 h
-
Result:Inhibited beclin-1 production at higher concentrations in K562 leukemia cells.
Chemical Information
-
Appearance Solid
-
Molecular Weight 635.65
-
Formula C29H32F3N5O6S
-
SMILES
O=C(O)C(F)(F)F.CC(C)(N1C=C(C(C2=CC(O)=CC=C2)=N1)C3=CC=NC(NCCCNS(=O)(C4=CC=C(C=C4)O)=O)=C3)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)